Literature DB >> 12112885

One core laboratory at two international sites, is that feasible? An inter-core laboratory and intra-observer variability study.

Joan C Tuinenburg1, Gerhard Koning, Ellen Hekking, Colette Desjardins, François Harel, Luc Bilodeau, Anton W M van Weert, Jacques Lespérance, Johan H C Reiber.   

Abstract

To assess the magnitude of differences in QCA outcomes between two cooperating core laboratories in a single trial, we have carried out an inter-core laboratory variability study. Two QCA experts at the Montreal Heart Institute and Heart Core Leiden both analyzed 32 lesions (pre- and post-intervention) in accordance with previously agreed upon standard operating procedures. One of the experts analyzed the whole image set twice to determine the intraobserver variability. The inter-core laboratory differences in the acute gain (n = 31 pairs) are non-significant. The systematic errors of the individual measurements (n = 63 analyses) show an excellent intraclass correlation coefficient of reliability (>75%), except for the stent length (67.7%). The corresponding random errors are small. In general, the intra-observer systematic and random errors are both slightly smaller than those for the inter-core laboratory study. QCA analyses in clinical trials can be carried out in core laboratories at two different locations if and only if highly standardized conditions are maintained. Copyright 2002 Wiley-Liss, Inc.

Mesh:

Year:  2002        PMID: 12112885     DOI: 10.1002/ccd.10189

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  7 in total

1.  Variability of quantitative coronary angiography: an evaluation of on-site versus core laboratory analysis.

Authors:  Rasmus Moer; Anton W M van Weert; Yngvar Myreng; Per Mølstad
Journal:  Int J Cardiovasc Imaging       Date:  2003-12       Impact factor: 2.357

2.  Quantitative coronary analysis in the Nordic Bifurcation studies.

Authors:  Niels R Holm; Helle Højdahl; Jens F Lassen; Leif Thuesen; Michael Maeng
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-07       Impact factor: 2.357

3.  A CYP26B1 polymorphism enhances retinoic acid catabolism and may aggravate atherosclerosis.

Authors:  Olesya Krivospitskaya; Ali Ateia Elmabsout; Eva Sundman; Leif A Söderström; Olga Ovchinnikova; Andreas C Gidlöf; Nikolai Scherbak; Giuseppe Danilo Norata; Ann Samnegård; Hans Törmä; Samy M Abdel-Halim; Jan-Håkan Jansson; Per Eriksson; Allan Sirsjö; Peder S Olofsson
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

4.  Inter- and intra-core laboratory variability in the quantitative coronary angiography analysis for drug-eluting stent treatment and follow up.

Authors:  Shigenori Ito; Kanako Kinoshita; Akiko Endo; Ryoko Kami; Yuko Kotake; Masato Nakamura
Journal:  Ther Adv Cardiovasc Dis       Date:  2020 Jan-Dec

5.  Angiographic core laboratory reproducibility analyses: implications for planning clinical trials using coronary angiography and left ventriculography end-points.

Authors:  Terje K Steigen; Cheryl Claudio; David Abbott; Michael Schulzer; Jeff Burton; Wayne Tymchak; Christopher E Buller; G B John Mancini
Journal:  Int J Cardiovasc Imaging       Date:  2007-12-12       Impact factor: 2.357

6.  Accuracy of 3-dimensional and 2-dimensional quantitative coronary angiography for predicting physiological significance of coronary stenosis: a FAVOR II substudy.

Authors:  Daixin Ding; Junqing Yang; Jelmer Westra; Yundai Chen; Yunxiao Chang; Martin Sejr-Hansen; Su Zhang; Evald H Christiansen; Niels R Holm; Bo Xu; Shengxian Tu
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

7.  Validity of tortuosity severity index in chest pain patients with abnormal exercise test and normal coronary angiography.

Authors:  Ayman K M Hassan; Hatem Abd-El Rahman; Safaa Gomaa Hassan; Tarek A N Ahmed; Amr Ahmed Aly Youssef
Journal:  Egypt Heart J       Date:  2018-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.